Bmf-219
Multiple Myeloma, Acute Myeloid Leukemia, Cancer, Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, Lymphoma, Acute Lymphoblastic Leukemia, Plasma Cell Myeloma, Myeloma, Plasma-Cell, Myelomatosis, Acute Mixed-Phenotype Leukemia, Refractory, Progression
Terminated
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
―